Aristeia Capital L.L.C. Invests $290,000 in DaVita Inc. $DVA

Key Points

• Aristeia Capital L.L.C. has purchased 1,896 shares of DaVita Inc., valued at approximately $290,000, as reported in their recent SEC filing.
• The stock has seen recent activity from institutional investors, with a total of 90.12% of DaVita's stock owned by institutions and hedge funds.
• Despite a strong quarterly earnings report, DaVita's stock has seen a 2.5% decrease in trading, with an average price target from analysts of $164.00.

Aristeia Capital L.L.C. bought a new position in DaVita Inc. (NYSE:DVA - Free Report) in the first quarter, according to its most recent disclosure with the SEC. The firm bought 1,896 shares of the company's stock, valued at approximately $290,000.

A number of other hedge funds and other institutional investors have also modified their holdings of DVA. UMB Bank n.a. increased its stake in shares of DaVita by 65.5% in the 1st quarter. UMB Bank n.a. now owns 192 shares of the company's stock worth $29,000 after acquiring an additional 76 shares during the last quarter. Copia Wealth Management acquired a new stake in shares of DaVita in the 4th quarter worth $30,000. National Pension Service increased its stake in shares of DaVita by 74.3% in the 1st quarter. National Pension Service now owns 197 shares of the company's stock worth $30,000 after acquiring an additional 84 shares during the last quarter. Y.D. More Investments Ltd acquired a new stake in shares of DaVita in the 1st quarter worth $35,000. Finally, NewEdge Advisors LLC increased its stake in shares of DaVita by 20.8% in the 1st quarter. NewEdge Advisors LLC now owns 511 shares of the company's stock worth $78,000 after acquiring an additional 88 shares during the last quarter. 90.12% of the stock is owned by institutional investors and hedge funds.

Insider Activity

In other news, insider James O. Hearty sold 2,351 shares of the business's stock in a transaction dated Wednesday, July 23rd. The stock was sold at an average price of $150.00, for a total transaction of $352,650.00. Following the completion of the transaction, the insider directly owned 26,038 shares of the company's stock, valued at approximately $3,905,700. The trade was a 8.28% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. Insiders own 1.50% of the company's stock.

Wall Street Analyst Weigh In

DVA has been the subject of a number of recent analyst reports. Truist Financial set a $148.00 price objective on DaVita in a research report on Friday, August 8th. Bank of America cut their price objective on DaVita from $145.00 to $140.00 and set an "underperform" rating for the company in a research report on Wednesday. Barclays cut their price objective on DaVita from $169.00 to $160.00 and set an "equal weight" rating for the company in a research report on Thursday, August 7th. Finally, Wall Street Zen raised DaVita from a "hold" rating to a "buy" rating in a research report on Saturday. Three equities research analysts have rated the stock with a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat, DaVita presently has an average rating of "Reduce" and an average price target of $158.00.

DaVita Trading Down 0.1%

NYSE DVA traded down $0.16 during trading on Friday, hitting $133.08. The stock had a trading volume of 481,674 shares, compared to its average volume of 661,071. The company has a market capitalization of $9.52 billion, a PE ratio of 13.09, a PEG ratio of 0.95 and a beta of 1.13. The company has a quick ratio of 1.34, a current ratio of 1.39 and a debt-to-equity ratio of 23.18. The firm has a 50 day moving average price of $138.45 and a 200 day moving average price of $141.47. DaVita Inc. has a twelve month low of $126.07 and a twelve month high of $179.60.

DaVita (NYSE:DVA - Get Free Report) last released its earnings results on Tuesday, August 5th. The company reported $2.95 earnings per share for the quarter, beating the consensus estimate of $2.70 by $0.25. The company had revenue of $3.38 billion during the quarter, compared to the consensus estimate of $3.36 billion. DaVita had a return on equity of 369.39% and a net margin of 6.35%.DaVita's revenue was up 6.1% compared to the same quarter last year. During the same period in the previous year, the company posted $2.00 EPS. DaVita has set its FY 2025 guidance at 10.200-11.300 EPS. As a group, equities research analysts forecast that DaVita Inc. will post 10.76 earnings per share for the current year.

DaVita Company Profile

DaVita Inc provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers.